Combining Cannabinoids
April 4, 2022
Published by input.receiving on April 4, 2022
Categories
This early study on rats and rabbits explored a range of potential site effects of the use of various cannabinoids and combinations. Notably, it concluded that the effects of THC were increased in impact and duration by the presence of CBN; measured by time to sleep, induce catantonia, and its capacity to work as an analgestic (pain reliever).
April 4, 2022
Published by input.receiving on April 4, 2022
Categories
This study conducted to observe the psychoactive effects of dosing THC in concert with CBD as well as each independantly concluded that CBD does indeed mitigate the "euphoric" effects of THC as well as other "THC-like effects", on its own CBD was shown to be innactive for all psychoactivity parameters measured.
October 22, 2021
Published by Ciara Admin on October 22, 2021
Categories
The high MC monthly dose group consumed higher levels of most phyto-cannabinoids and terpenes, but that was not the case for all of the cannabis components. The high dose consumers and the ones with lower ASRS score reported a higher occurrence of stopping all ADHD medications. Moreover, there was an association between lower ASRS score subgroup and lower anxiety scores. In addition, we found an association between lower ASRS score and consumption of high doses of cannabinol (CBN), but not with Δ-9-tetrahydrocannabinol (THC). Conclusion: These findings reveal that the higher-dose consumption of MC components (phyto-cannabinoids and terpenes) is associated with ADHD medication reduction. In addition, high dosage of CBN was associated with a lower ASRS score. However, more studies are needed in order to fully understand if cannabis and its constituents can be used for management of ADHD.